Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation

BACKGROUND: Multiple studies have failed to reveal an effective method for preventing the recurrence of primary sclerosing cholangitis (PSC) after liver transplantation (LTx). A national study conducted in Japan revealed several risk factors for the recurrence after living donor LTx (LDLTx); however...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yohei, Hoshino, Ken, Fuchimoto, Yasushi, Matsubara, Kentaro, Hibi, Taizo, Yagi, Hiroshi, Abe, Yuta, Shinoda, Masahiro, Kitago, Minoru, Obara, Hideaki, Yagi, Takahito, Okajima, Hideaki, Kaido, Toshimi, Uemoto, Shinji, Suzuki, Tatsuya, Kubota, Keiichi, Yoshizumi, Tomoharu, Maehara, Yoshihiko, Inomata, Yukihiro, Kitagawa, Yuko, Egawa, Hiroto, Kuroda, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811271/
https://www.ncbi.nlm.nih.gov/pubmed/29464203
http://dx.doi.org/10.1097/TXD.0000000000000760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811271/
https://www.ncbi.nlm.nih.gov/pubmed/29464203
http://dx.doi.org/10.1097/TXD.0000000000000760

Ejemplares similares